Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth.
Circulation
; 145(15): 1154-1168, 2022 04 12.
Article
in En
| MEDLINE
| ID: mdl-35317609
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myocardial Reperfusion Injury
/
Heart Failure
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Circulation
Year:
2022
Type:
Article
Affiliation country:
China